Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 24 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysisChen, C.; Kostakis, C.; Harpas, P.; Felgate, P.; Irvine, R.; White, J.
2012Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infantsGordon, A.; Lopatko, O.; Haslam, R.; Stacey, H.; Pearson, V.; Woods, A.; Fisk, A.; White, J.
2013Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessmentsChen, C.; Kostakis, C.; Irvine, R.; Felgate, P.; White, J.
2010Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimenAuclair, D.; Finnie, J.; White, J.; Nielsen, T.; Fuller, M.; Kakkis, E.; Cheng, A.; O'Neill, C.; Hopwood, J.
2011Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' usersMorefield, K.; Keane, M.; Felgate, P.; White, J.; Irvine, R.
2011Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depressionMajumder, I.; White, J.; Irvine, R.
2011Population drug use in Australia: A wastewater analysisIrvine, R.; Kostakis, C.; Felgate, P.; Jaehne, E.; Chen, C.; White, J.
2013Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)Chen, C.; Kostakis, C.; Irvine, R.; White, J.
2011Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjectsHay, J.; La Vincente, S.; Somogyi, A.; Chapleo, C.; White, J.
2012The effect of methadone on emotional reactivitySavvas, S.; Somogyi, A.; White, J.